Skip to main content
Premium Trial:

Request an Annual Quote

Cellomics Raises $10.5M In Venture Funding

Premium

PITTSBURGH--Cellomics, a company here whose drug discovery technology platform includes proprietary bioinformatics software, has raised $10.5 million in private venture funding. The venture syndicate was led by InterWest Partners and Axiom Venture Partners, along with Delphi Ventures and Oxford Bioscience Partners. Gerard Klauer Mattison served as investment consultants.

Previous investors in the company, which was formerly known as BioDx, include Carl Zeiss, Komasta Properties, Tycho Investors, and the founders. Cellomics focuses on cell-based screening technologies for target validation and lead optimization for new drug candidates. The company offers an integrated screening platform that includes fluorescence assays, a high-content screening system, and bioinformatics software, all designed to provide detailed biological information about a drug candidate's physiological effects on specific cellular targets.

In addition, Cellomics announced, it is developing a proprietary database product and what it called a "next-generation, cell-based screening platform," known as the CellChip System, plus the company will comarket an ultrahigh-throughput screening system, as well as its high-content screening system, through an exclusive, worldwide alliance with Carl Zeiss Jena. Cellomics was founded by Lansing Taylor, Alan Waggoner, Terry Dunlay, Michel Nederlof, John Boles, and LeRoy Metz.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.